In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...

Cancer therapies called checkpoint inhibitor drugs, which ratchet up the immune system, work better when this bacterium is ...

Key TakeawaysThe weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer. Tumor ...

Researchers from the National Museum of Natural Sciences in Madrid, Spain, digitally reconstructed the ribcages of four ...

A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors.

In a new study, researchers have uncovered how exercise might help the immune system fight cancer: by changing the gut ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

RNA bundled in lipid nanoparticles trains T cells in mice to eliminate cancer. Coupled with noninvasive imaging, researchers tracked the in situ CAR-T cells to assess their effectiveness and safety.

Following on from their breakthrough human trial that successfully reprogrammed the immune system to overpower glioblastoma, ...

Anti-diabetic and obesity drug, tirzepatide induced weight loss in obese mice and reduced growth of breast cancer tumors. | ...

New preclinical research shows a promising drug combination that targets ovarian cancer’s survival pathways, paving the way ...